Morphosys moves closer to getting first antibody drug on market
 

Morphosys moves closer to getting first antibody drug on market
FRANKFURT (Reuters) - German biotech Morphosys moved a step closer to getting its first antibody drug onto the market as its licensee, Johnson & Johnson unit Jenssen, reported positive results from a phase 3 study of psoriasis drug guselkumab.http://feeds.feedburner.com/~ff/reut...?d=yIl2AUoC8zA http://feeds.feedburner.com/~ff/reut...dY:F7zBnMyn0Lo http://feeds.feedburner.com/~ff/reut...dY:V_sGLiPBpWU
http://feeds.feedburner.com/~r/reute...~4/5gcwK2L67i8